Use of prescription antiobesity drugs in the United States.

ABSTRACT:

Study objective

To examine national trends in prescription antiobesity drug use in the United States.

Design

Data analysis.

Data source

The IMS Health Vector One National and Total Patient Tracker and Encuity Research Treatment Answers databases, the Source Healthcare Analytics Source Lx database, and IMS LifeLink database.

Measurements and main results

National drug use estimates from 1991-2011 were extracted from the IMS Health Vector One National database, and patient characteristics from 2008-2011 were extracted from the Vector One Total Patient Tracker and Encuity Research Treatment Answers databases. The Source Healthcare Analytics Source Lx database was used to examine duration of antiobesity drug use from 2002-2011, with a sensitivity analysis performed

SUBMITTER: Hampp C 

PROVIDER: S-EPMC4740913 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature